Biomarkers of response to camrelizumab combined with apatinib: an analysis from a phase II trial in recurrent/metastatic nasopharyngeal carcinoma.
Saved in:
| Title: | Biomarkers of response to camrelizumab combined with apatinib: an analysis from a phase II trial in recurrent/metastatic nasopharyngeal carcinoma. |
|---|---|
| Authors: | Lan, Kaiqi1,2 (AUTHOR), Li, Shibing3 (AUTHOR), Jia, Guodong1,2 (AUTHOR), Li, Suchen1,2 (AUTHOR), Xie, Siyi1,2 (AUTHOR), Tang, Linquan1,2 (AUTHOR), Mai, Haiqiang1,2 (AUTHOR) maihq@mail.sysu.edu.cn, Yuan, Li1,2 (AUTHOR) yuanli@sysucc.org.cn |
| Source: | British Journal of Cancer. Oct2025, Vol. 133 Issue 6, p886-895. 10p. |
| Database: | Academic Search Ultimate |
| ISSN: | 00070920 |
|---|---|
| DOI: | 10.1038/s41416-025-03044-y |
